Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literature

Peer Review reports

Original Submission
19 Sep 2023	Submitted	Original manuscript
26 Sep 2023	Reviewed	Reviewer Report - Adil Mohammed
28 Sep 2023	Reviewed	Reviewer Report - Subramanya shyam Ganti
9 Oct 2023	Author responded	Author comments - Peng Ning
Resubmission - Version 2
9 Oct 2023	Submitted	Manuscript version 2
17 Oct 2023	Reviewed	Reviewer Report - Adil Mohammed
26 Oct 2023	Reviewed	Reviewer Report - Ram Yalamanchili
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
7 Nov 2023	Editorially accepted
22 Jan 2024	Article published	10.1186/s13256-023-04248-7

Back to article page